A Pathologist’s Perspective: The Role of Biomarker Testing in Metastatic Colorectal Cancer

Host: Jennifer Caudle, DO <br> Guest: Fernando Uriel Garcia, MD <br> <p>Pathologist Fernando Uriel Garcia, MD provides his perspective on the importance of the biomarkers in determining patient prognosis and potential implications depending on a patient's biomarker status.</p> <p> </p> <p style="text-align: left;"><span><span> © 2021 Pfizer Inc. All rights reserved. </span>PP-BCE-USA-0289 April 2021</span></p>